<p><b>Copyright information:</b></p><p>Taken from "Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer"</p><p>http://www.biomedcentral.com/1471-2407/7/231</p><p>BMC Cancer 2007;7():231-231.</p><p>Published online 20 Dec 2007</p><p>PMCID:PMC2241632.</p><p></p
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel combined ...
located on the World Wide Web at: The online version of this article, along with updated information...
<p><b>Copyright information:</b></p><p>Taken from "Phase I dose escalation study of vinorelbine and ...
Abstract Background A platinum doublet is the current standard treatment for good performance status...
<p><b>Copyright information:</b></p><p>Taken from "Phase I/II study of first-line irinotecan combine...
Purpose: Pemetrexed and vinorelbine are active antineoplastic agents in non-small cell lung cancer (...
The aim of the study was to determine the maximum tolerated dose (MTD) for the combination of high-d...
<p><b>Copyright information:</b></p><p>Taken from "A phase II trial of docetaxel and erlotinib as fi...
<p><b>Copyright information:</b></p><p>Taken from "Results of paclitaxel (day 1 and 8) and carboplat...
<p><b>Copyright information:</b></p><p>Taken from "Results of paclitaxel (day 1 and 8) and carboplat...
PURPOSE:This study aimed to evaluate the safety, tolerability and pharmacokinetics of the combinatio...
Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel com-bined...
<p>Mean plasma concentration-time curves of OSI-420 (A) on Day 3 after initial oral dose with CSV do...
Purpose: The purpose of the present phase II trial was to determine the efficacy and toxicity of vin...
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel combined ...
located on the World Wide Web at: The online version of this article, along with updated information...
<p><b>Copyright information:</b></p><p>Taken from "Phase I dose escalation study of vinorelbine and ...
Abstract Background A platinum doublet is the current standard treatment for good performance status...
<p><b>Copyright information:</b></p><p>Taken from "Phase I/II study of first-line irinotecan combine...
Purpose: Pemetrexed and vinorelbine are active antineoplastic agents in non-small cell lung cancer (...
The aim of the study was to determine the maximum tolerated dose (MTD) for the combination of high-d...
<p><b>Copyright information:</b></p><p>Taken from "A phase II trial of docetaxel and erlotinib as fi...
<p><b>Copyright information:</b></p><p>Taken from "Results of paclitaxel (day 1 and 8) and carboplat...
<p><b>Copyright information:</b></p><p>Taken from "Results of paclitaxel (day 1 and 8) and carboplat...
PURPOSE:This study aimed to evaluate the safety, tolerability and pharmacokinetics of the combinatio...
Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel com-bined...
<p>Mean plasma concentration-time curves of OSI-420 (A) on Day 3 after initial oral dose with CSV do...
Purpose: The purpose of the present phase II trial was to determine the efficacy and toxicity of vin...
<p>Mean plasma concentration-time curves of vinorelbine (A) on Day 1 after initial oral dose with CS...
Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel combined ...
located on the World Wide Web at: The online version of this article, along with updated information...